Hypercalcemia and osteoblastic lesions induced by 13-cis-retinoic acid mimicking relapsed neuroblastoma

Pediatric Blood and Cancer

Volumn 53, Issue 4, 2009, Pages 666-668

  Cross, Siobhan F ^a   Dalla Pozza, Luciano ^a   Munns, Craig F ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

13 cis retinoic acid; Hypercalcemia; Neuroblastoma; Osteoblastic lesions

Indexed keywords

(3 IODOBENZYL)GUANIDINE; C REACTIVE PROTEIN; CALCIUM; CARBOPLATIN; CISPLATIN; CREATININE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FUROSEMIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; ISOTRETINOIN; MELPHALAN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CH14.18; OSTEOCALCIN; PAMIDRONIC ACID; PARATHYROID HORMONE; PHOSPHATE; TECHNETIUM 99M; UNCLASSIFIED DRUG; VINCRISTINE; DIAGNOSTIC AGENT;

ABDOMINAL MASS; ARTICLE; AUTOTRANSPLANTATION; BONE LESION; BONE METASTASIS; BONE PAIN; BONE SCINTISCANNING; BONE TURNOVER; CALCIUM BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CASE REPORT; CATECHOLAMINE URINE LEVEL; CHILD; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DRUG DOSE REDUCTION; GLOMERULUS FILTRATION RATE; HUMAN; HYPERCALCEMIA; HYPERGLYCEMIA; HYPOTENSION; LEG PAIN; LOW DRUG DOSE; MALE; MULTIMODALITY CANCER THERAPY; NEPHRECTOMY; NEUROBLASTOMA; NEUROPATHIC PAIN; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRESCHOOL CHILD; PRIORITY JOURNAL; TUMOR BIOPSY; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; OSTEOBLAST; PATHOLOGY; TUMOR RECURRENCE;

3-IODOBENZYLGUANIDINE; CHILD; HUMANS; HYPERCALCEMIA; ISOTRETINOIN; MALE; NEOPLASM RECURRENCE, LOCAL; NEUROBLASTOMA; OSTEOBLASTS;

EID: 69849087727     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22052     Document Type: Article

References (15)

1. Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation and 13-cis-retinoic acid. N Engl J Med 1999;341:1165-1173.
2. Theile CJ, Reynolds CP, Israel MA. Decreased expression of N-myc preceeds retinoic acid induced morphological differentiation of human neuroblastoma. Nature 1985;313:404-406. (Pubitemid 15198727)
3. Villablanca JG, Khan AA, Avramis VI, et al. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. J Clin Oncol 1995;13:894-901.
4. Cassidy J, Lippman M, La Croix A, et al. Phase II trial of 13-cis-retinoic acid in metastatic breast cancer. Eur J Cancer Clin Oncol 1982;18:925-928. (Pubitemid 13147891)
5. Pittsley RA, Yoder FW. Retinoid hyperostosis. N Engl J Med 1983;308:1012-1014.
6. DiGiovanna J. Isotretinoin effects on bone. J Am Acad Dermatol 2001;45:S176-S182.
7. Atalay A, Altaykan A, Ergin G, et al. Reversible sclerotic changes of lumbar spine and femur due to long-term oral isotretinoin therapy. Rheumatol Int 2004;24:197-300. (Pubitemid 39286913)
8. Lawson JP. Drug induced lesions of the musculoskeletal system. Radiologic Clinics of North America 1990;28:233-246. (Pubitemid 20096568)
9. Bachrach LK, Ward LM. Clinical review. Bisphosphonate use in childhood osteoporosis. J Clin Endocrinol Metab 2009;94:400-409.
10. Nishimura G, Mugishima H, Hirao J, et al. Generalized metaphyseal modification with cone-shaped epiphyses following long-term administration of 13-cis-retinoic acid. Eur J Pediatr 1997;156:432-435. (Pubitemid 27261503)
11. Grissom LE, Griffin GC, Mandell GA. Hypervitaminosis A as a complication of treatment for neuroblastoma. Pediatr Radiol 1996;26:200-202.
12. Marabelle A, Sapin V, Rousseau R. et al. Hypercalcemia and 13-cis-retinoic acid in post-consolidation therapy of neuroblastoma. Pediatr Blood Cancer 2009;52:280-283.
13. van Beek E, Lowik C, Karperien M, et al. Independent pathways in the modulation of osteoclastic resorptioin by intermediates of the mevalonate biosynthetic pathway: The role of the retinoic acid receptor. Bone 2006;38:167-171. (Pubitemid 43165782)
14. Skillington J, Choy L, Derynck R. Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast defferentiation of preadipocytes. J Cell Biol 2002;159:135-146. (Pubitemid 35191525)
15. Torok L, Galuska L, Kasa M, et al. Bone-scintigraphic examinations in patients treated with retinoids: A prospective study. Br J Derm 1989;120:31-36. (Pubitemid 19032888)